IRFEN Junior susp 100 mg/5ml fl 200 ml
7680669330019
CH-66933
M01AE01
07.10.1.
Reimbursement limitations:
ALGIFOR
Pris en charge uniquement chez les enfants et les adolescents jusqu'à 18 ans.
1 / 3
google
Details
- Product number
- 6693301
- CPT
- -
- Packaging group
- 200
- Unit
- ml
- Composition
- ibuprofenum 100 mg, acidum citricum, xanthani gummi, hypromellosum, glycerolum, natrii chloridum, polysorbatum 80, aromatica (Orange) cum alcohol benzylicus q.s., vanillinum, natrii cyclamas, maltitolum liquidum 2 g, acesulfamum kalicum, sucralosum, natrii benzoas 10 mg, aqua, ad suspensionem pro 5 ml corresp. natrium 7.375 mg.
Articles (1)
Irfen Junior, Suspension
suspension
200
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
100.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | AROMA |
|
(N/A)
|
- | Substance | HBESI |
|
(N/A)
|
- | Substance | AIMDK |
|
(N/A)
|
- | Substance | AIMDK |
|
(N/A)
|
2.0 G | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
10.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
7.375 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 13.55
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/02/2019
Authorization holder
Mepha Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 66933
- Drug name
- Irfen Junior, Suspension
- Galenic form
- SUOR
- ATC Code
- M01AE01
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 07/12/2018
- Authorization expiration date
- 31/12/9999
- IT number
- 07.10.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- IRFEN Junior susp 100 mg/5ml fl 200 ml
- Description (DE)
- IRFEN Junior Susp 100 mg/5ml Fl 200 ml
- Market launch
- 07/12/2018
- Narcotic (BTM)
- No